Skip to main content
. 2016 Sep 20;312(6):F1016–F1025. doi: 10.1152/ajprenal.00601.2015

Table 1.

Ideal blocking peptide characteristics

Shortest amino acid sequence disrupting single protein-protein interaction
Adequate uptake by target cell/tissue
Short serum half-life
Prolonged biological half-life
Minimally antigenic (HLA haplotype matching might reduce antigenicity, especially if repeated peptide doses are administered)

HLA, human leukocyte antigen.